Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics/pharmacodynamics of CKD-519 in dyslipidemia; the trial has completed.
-
CLINICAL_TRIALS research · 2017-07-07Clinical Trial Update: A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. [Phase 1]
Phase 1 study in healthy volunteers assessing safety, tolerability, and pharmacokinetics after a single oral dose of an investigational prod…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia [Phase 3]
A completed Phase 3 trial evaluated the effects of a Coenzyme Q10 dietary supplement on dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort
Phase II Cork and Kerry Diabetes and Heart Disease Study (Mitchelstown Cohort) has completed; the update pertains to cardiovascular disease …
-
FDA approval · 2017-06-16FDA Approved: NIACIN — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's NIACIN generic (nicotinic acid) under ANDA 203899. The approval covers a generic niacin product indicated f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects [Phase 1]
A Phase 1 repeat-dose food-effect study of the investigational compound GSK256073F in healthy adult subjects has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) [Phase 3]
Phase 3 study evaluating safety and efficacy of adding Anacetrapib to ongoing statin therapy in Japanese participants with dyslipidemia; the…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Effects of Exercise on Fructose-induced Postprandial Lipemia [NA]
This completed clinical trial evaluated whether exercise modulates fructose-induced postprandial lipemia in adults with a sedentary lifestyl…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks [NA]
This completed clinical trial assessed the metabolic effects of consuming sugar-sweetened beverages for two weeks in adults with metabolic s…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks [NA]
A completed clinical trial evaluated the effects of consuming sugar-sweetened beverages with meals for 10 weeks in individuals with metaboli…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol [Phase 2]
Phase 2 trial update for GW501516 in individuals with low HDL cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Fluvastatin in Adults With Dislipidemia With History of Muscle Problems [Phase 4]
This Phase 4 trial evaluating fluvastatin in adults with dyslipidemia and a history of muscle problems has completed.
-
FDA approval · 2017-05-12FDA Approved: FENOFIBRIC ACID — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic fenofibric acid product manufactured by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Study Comparing Fish Oil and Krill Oil [NA]
The Tufts University-sponsored trial comparing fish oil with krill oil for inflammation and dyslipidemia was terminated.
-
CLINICAL_TRIALS research · 2017-04-24Clinical Trial Update: The Role of Sleeve Gastrectomy in Dyslpidemia
This clinical trial update discusses the potential impact of sleeve gastrectomy on dyslipidemia in individuals with obesity.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women [Phase 3]
A Phase 3 clinical trial evaluating the impact of weight management programs on cardiometabolic risk in overweight women. The study status i…
-
FDA approval · 2017-04-07FDA Approved: FENOFIBRATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for Fenofibrate (generic), a lipid-lowering drug for hyperlipidemia, hypertriglyceridemia, …
-
CLINICAL_TRIALS research · 2017-03-29Clinical Trial Update: Nutrition and Exercise Intervention Study [NA]
A Clinical Trial Update for a Nutrition and Exercise Intervention Study (NCT00926744) sponsored by the NIH, examining potential effects on h…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. [Phase 4]
Phase 4 clinical trial evaluating combination cholesterol therapies in patients with high cholesterol; status is completed.
-
FDA approval · 2017-03-21FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Ascend Laboratories, LLC)
FDA approves the original ANDA for rosuvastatin calcium from Ascend Laboratories, LLC, enabling the generic rosuvastatin calcium product to …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome [Phase 4]
The document reports a Phase 4 clinical trial update from Novartis focused on reducing overall cardiovascular risk in patients with metaboli…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial updating on the efficacy of a fluvastatin plus fenofibrate regimen versus a simvastatin plus ezetimibe regimen in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers [Phase 4]
Phase 4 trial evaluating the efficacy of fluvastatin on certain markers in dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) [Phase 2]
A Phase 2 investigational drug study for dyslipidemia has completed. The snippet does not provide efficacy results.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia [Phase 3]
Phase III randomized, double-blind, multicenter trial comparing the combination of fimasartan and rosuvastatin to each component alone in pa…